Document Classification

Section Type: OBJECTIVE

Text: To assess the efficacy of Sn-mesoporphyrin (SnMP), a potent inhibitor of bilirubin production, in : a) moderating the need for phototherapy (PT) in full-term breastfed infants with plasma bilirubin concentrations (PBC) of > / = 256. 5 micromol/L and < / = 307. 8 micromol/L (> / = 15 mg/dL and < / = 18 mg/dL, respectively) that were reached between > / = 48 and < / = 96 hours of age ; b) diminishing the time required for the PBC to decline to < / = 222. 3 micromol/L (< / = 13 mg/dL) (closure of the case) ; c) decreasing the number of bilirubin determinations required for monitoring hyperbilirubinemia.